Bipartisan Lawmakers Question Drug Makers, Vendors on Price Transparency

Bipartisan Lawmakers Question Drug Makers, Vendors on Price Transparency

Rep. Morgan Griffith (R-Va.) asks questions during a hearing in Washington on May 14, 2020. Greg Nash/Pool/Getty Images

Bipartisan House members questioned pharmaceutical industry leaders on Feb. 11, seeking to learn how the complicated drug supply chain may increase the cost of prescription medications.

“One of the most frustrating aspects of the supply chain is that it operates as if in a black box,” Rep. Morgan Griffith (R-Va.) said in opening the hearing by the Health Subcommittee of the House Energy and Commerce Committee.

We had a problem loading this article. Please enable javascript or use a different browser. If the issue persists, please visit our help center.

Original News Source Link – Epoch Times

Running For Office? Conservative Campaign Consulting – Election Day Strategies!